======= TMSB4X ======= == Gene Information == * **Official Symbol**: TMSB4X * **Official Name**: thymosin beta 4 X-linked * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=7114|7114]] * **UniProt**: [[https://www.uniprot.org/uniprot/P62328|P62328]] * **Interactions**: [[https://thebiogrid.org/search.php?search=TMSB4X&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TMSB4X|Open PubMed]] * **OMIM**: [[https://omim.org/entry/300159|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Plays an important role in the organization of the cytoskeleton (By similarity). Binds to and sequesters actin monomers (G actin) and therefore inhibits actin polymerization. {ECO:0000250}. |Thymosin| |positive regulation of proton-transporting ATP synthase activity, rotational mechanism| |regulation of proton-transporting ATP synthase activity, rotational mechanism| |negative regulation of interleukin-8 secretion| |negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding| |cytoplasmic sequestering of NF-kappaB| |sequestering of actin monomers| |positive regulation of ATP biosynthetic process| |regulation of RNA polymerase II regulatory region sequence-specific DNA binding| |positive regulation of endothelial cell chemotaxis| |cytoplasmic sequestering of transcription factor| |regulation of ATP biosynthetic process| |negative regulation of interleukin-8 production| |negative regulation of transcription regulatory region DNA binding| |regulation of endothelial cell chemotaxis| |regulation of proton transport| |negative regulation of NIK/NF-kappaB signaling| |positive regulation of nucleotide biosynthetic process| |positive regulation of purine nucleotide biosynthetic process| |cytoplasmic sequestering of protein| |regulation of interleukin-8 secretion| |actin monomer binding| |regulation of purine nucleotide biosynthetic process| |regulation of nucleotide biosynthetic process| |positive regulation of ATP metabolic process| |positive regulation of nucleotide metabolic process| |positive regulation of purine nucleotide metabolic process| |regulation of transcription regulatory region DNA binding| |negative regulation of actin filament polymerization| |positive regulation of blood vessel endothelial cell migration| |negative regulation of DNA binding| |negative regulation of protein polymerization| |platelet alpha granule lumen| |negative regulation of cytokine secretion| |regulation of interleukin-8 production| |maintenance of protein location in cell| |negative regulation of NF-kappaB transcription factor activity| |regulation of blood vessel endothelial cell migration| |maintenance of location in cell| |positive regulation of endothelial cell migration| |positive regulation of ion transmembrane transporter activity| |maintenance of protein location| |regulation of NIK/NF-kappaB signaling| |positive regulation of transporter activity| |regulation of purine nucleotide metabolic process| |regulation of nucleotide metabolic process| |tumor necrosis factor-mediated signaling pathway| |regulation of ATP metabolic process| |regulation of DNA binding| |platelet degranulation| |negative regulation of supramolecular fiber organization| |negative regulation of protein complex assembly| |negative regulation of protein secretion| |positive regulation of chemotaxis| |positive regulation of small molecule metabolic process| |negative regulation of cytoskeleton organization| |negative regulation of peptide secretion| |positive regulation of epithelial cell migration| |positive regulation of cation transmembrane transport| |positive regulation of ion transmembrane transport| |regulation of endothelial cell migration| |negative regulation of DNA-binding transcription factor activity| |maintenance of location| |regulation of actin filament polymerization| |negative regulation of binding| |negative regulation of protein transport| |regulation of actin polymerization or depolymerization| |regulation of actin filament length| |negative regulation of establishment of protein localization| |positive regulation of transmembrane transport| |negative regulation of secretion by cell| |regulation of cytokine secretion| |regulation of chemotaxis| |regulation of epithelial cell migration| |regulation of protein polymerization| |negative regulation of secretion| |actin filament organization| |cellular response to tumor necrosis factor| |regulation of ion transmembrane transporter activity| |regulation of actin filament organization| |response to tumor necrosis factor| |regulation of transmembrane transporter activity| |negative regulation of cytokine production| |positive regulation of ion transport| |regulation of transporter activity| |regulation of cation transmembrane transport| |regulation of inflammatory response| |regulation of actin cytoskeleton organization| |enzyme binding| |regulation of supramolecular fiber organization| |cytoskeleton| |negative regulation of organelle organization| |regulation of binding| |regulation of cellular component size| |regulation of actin filament-based process| |regulation of small molecule metabolic process| |regulation of DNA-binding transcription factor activity| |regulation of protein complex assembly| |supramolecular fiber organization| |regulation of protein secretion| |regulation of ion transmembrane transport| |negative regulation of transport| |actin cytoskeleton organization| |regulation of peptide secretion| |positive regulation of cell migration| |negative regulation of intracellular signal transduction| |regulation of anatomical structure size| |positive regulation of cell motility| |positive regulation of cellular component movement| |regulation of cytoskeleton organization| |positive regulation of locomotion| |regulation of transmembrane transport| |actin filament-based process| |positive regulation of response to external stimulus| |cytokine-mediated signaling pathway| |regulation of cytokine production| |regulation of ion transport| |regulated exocytosis| |negative regulation of cellular component organization| |regulation of protein transport| |regulation of peptide transport| |regulation of establishment of protein localization| |regulation of secretion by cell| |regulation of defense response| |exocytosis| |regulation of secretion| |regulation of cell migration| |regulation of cell motility| |regulation of cellular component biogenesis| |regulation of locomotion| |positive regulation of transport| |regulation of cellular component movement| |secretion by cell| |cellular response to cytokine stimulus| |regulation of protein localization| |export from cell| |regulation of response to external stimulus| |response to cytokine| |cytoskeleton organization| |secretion| |positive regulation of phosphate metabolic process| |positive regulation of phosphorus metabolic process| |negative regulation of molecular function| |negative regulation of multicellular organismal process| |negative regulation of signal transduction| |regulation of organelle organization| |negative regulation of cell communication| |negative regulation of signaling| |RNA binding| |regulation of response to stress| |cellular protein localization| |cellular macromolecule localization| |negative regulation of response to stimulus| |positive regulation of multicellular organismal process| |positive regulation of molecular function| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of intracellular signal transduction| |regulation of transport| |positive regulation of nucleobase-containing compound metabolic process| |extracellular region| |vesicle-mediated transport| |positive regulation of cellular biosynthetic process| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp352|Dexamethasone 0.006 to 0.015μM on day4 R07 exp352]]|-2.22| |[[:results:exp317|Geldanamycin 0.015 to 0.05μM on day4 R07 exp317]]|-1.73| |[[:results:exp225|Celastrol 0.12μM R05 exp225]]|-1.72| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/694 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/26| |bone|0/26| |breast|0/30| |central nervous system|0/49| |cervix|0/4| |colorectal|0/17| |esophagus|0/11| |fibroblast|0/1| |gastric|0/14| |kidney|0/18| |liver|0/19| |lung|0/72| |lymphocyte|0/16| |ovary|0/25| |pancreas|0/22| |peripheral nervous system|0/15| |plasma cell|0/12| |prostate|0/1| |skin|0/20| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/28| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 16189 * **Expression level (log2 read counts)**: 9.79 {{:chemogenomics:nalm6 dist.png?nolink |}}